2024 · JAMA network open · open access
Remote Monitoring and Data Collection for Decentralized Clinical Trials
Daly et al.
The finding, in our words
A survey of eight biopharmaceutical companies, representing a third of the oncology market, revealed that remote monitoring adoption in oncology trials trails other therapeutic areas. Electronic diaries and digital clinical outcome assessments are the most deployed tools, while local physician network visits are least used; respondents expect adoption to rise by over 40% for most technologies within five years, with digital recruitment and local imaging prioritised for improving patient centricity.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.